Rep. Ted Lieu (D-CA) suggested Wednesday that President Donald Trump may be receiving a special drug to treat a terminal illness.
The speculation follows the abrupt cancellation of a signing ceremony for the 21st Century ROAD to Housing Act [1]. The suggestion raises questions about the health and transparency of the U.S. presidency, as any significant medical impairment of a sitting president could impact national stability and governance.
Lieu spoke during a briefing for House Democratic leaders in Washington, D.C. He linked the president's last-minute decision to cancel the housing bill event to the possibility of a severe medical condition. Lieu questioned whether the president had been administered a specific new medication to manage such a condition.
"Did Donald Trump get this special drug?" Lieu said [2].
Lieu urged the administration to be open about the president's health status, suggesting that the sudden schedule change served as a potential indicator of a deeper crisis. He said that the White House needs to come clean [3].
"He may have a terminal illness," Lieu said [4].
The White House denied that the president is dealing with a terminal illness or receiving any such special treatment [5]. The administration has not provided further specific details regarding the reasons for the cancellation of the 21st Century ROAD to Housing Act [1] signing ceremony.
Lieu's comments come amid a broader effort by Democratic leaders to scrutinize the current administration's agenda and the president's ability to fulfill his duties. The congressman's remarks focus on the need for public disclosure when the health of the executive branch is called into question.
“"The White House needs to come clean."”
This incident highlights the recurring tension between a president's right to medical privacy and the public's interest in the health of the Commander in Chief. By linking a specific legislative delay—the 21st Century ROAD to Housing Act—to a medical theory, Rep. Lieu is attempting to use procedural anomalies as evidence of a fitness-for-duty crisis, a move that typically triggers intense partisan debate over transparency and stability.
